EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Stability Evaluation of 4-Phenylbutyric Acid-Loaded Nanocarrier Formulations for Topical Arsenical Medical Countermeasure Delivery

Nethra Viswaroopan, Meheli Ghosh, Jasim Khan, Ritesh K. Srivastava, Mohammad Athar, Ajay K. Banga

Journal of Pharmaceutical and BioTech Industry · 2026

DOI: 10.3390/jpbi3010003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and BioTech Industry, 2026. Verfasst von Nethra Viswaroopan und 5 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NIAMS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Effective topical delivery of 4-phenylbutyric acid (4-PBA) for arsenical vesicant-induced skin injury requires nanocarrier systems that maintain physicochemical and chemical stability during extended storage. This study systematically evaluated the six-month stability of five 4-PBA-loaded micro/nanoparticulate formulations—chitosan nanoparticles (N31, N35), emulsomes (E2), microsponges (MSs), and PLGA nanoparticles (P1)—to identify lead candidates suitable for field deployment and foam integration.

Methods

Formulations were subjected to ICH-accelerated stability testing at 25 °C/60% RH and 40 °C/75% RH, with monthly evaluation of particle size, polydispersity index, zeta potential, drug content by HPLC, and chemical/thermal stability by FTIR and DSC.

Results

N31 demonstrated superior colloidal stability, maintaining particle size within acceptable limits at both conditions despite progressive surface charge neutralization. E2 showed consistent drug content retention and preserved chemical integrity, though moderate vesicle fusion occurred. MS underwent complete physical degradation at 40 °C within the first month, while P1 exhibited hydrolytic degradation with substantial drug loss. N35 showed severe aggregation indicating colloidal instability.

Conclusions

N31 and E2 emerged as lead candidates: N31 is recommended for field deployment where environmental control is limited, while E2 is suitable for controlled storage settings prioritizing drug loading capacity.

Förderung

  • NIH/NIAMS

Zitieren

APA

Viswaroopan, N., Ghosh, M., Khan, J., Srivastava, R. K., Athar, M., & Banga, A. K. (2026). Comparative Stability Evaluation of 4-Phenylbutyric Acid-Loaded Nanocarrier Formulations for Topical Arsenical Medical Countermeasure Delivery. Journal of Pharmaceutical and BioTech Industry. https://doi.org/10.3390/jpbi3010003

Vancouver

Viswaroopan N, Ghosh M, Khan J, Srivastava RK, Athar M, Banga AK. Comparative Stability Evaluation of 4-Phenylbutyric Acid-Loaded Nanocarrier Formulations for Topical Arsenical Medical Countermeasure Delivery. Journal of Pharmaceutical and BioTech Industry. 2026. doi:10.3390/jpbi3010003

BibTeX
@article{Viswaroopan2026,
  author = {Viswaroopan, Nethra and Ghosh, Meheli and Khan, Jasim and Srivastava, Ritesh K. and Athar, Mohammad and Banga, Ajay K.},
  title = {Comparative Stability Evaluation of 4-Phenylbutyric Acid-Loaded Nanocarrier Formulations for Topical Arsenical Medical Countermeasure Delivery},
  journal = {Journal of Pharmaceutical and BioTech Industry},
  year = {2026},
  doi = {10.3390/jpbi3010003}
}
Kostenlos starten →